enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pramlintide - Wikipedia

    en.wikipedia.org/wiki/Pramlintide

    Pramlintide has been approved on 3/16/2005 by the FDA, for use by type 1 and type 2 diabetic patients who use insulin. [6] (subscription required) Pramlintide allows patients to use less insulin, lowers average blood sugar levels, and substantially reduces what otherwise would be a large unhealthy rise in blood sugar that occurs in diabetics right after eating.

  3. Teplizumab - Wikipedia

    en.wikipedia.org/wiki/Teplizumab

    Teplizumab has been used in clinical trials with the aim of protecting the remaining β-cells in people newly diagnosed with type 1 diabetes. [18] Immunomodulatory agents such as anti-CD3-antibodies may restore normal glucose control if provided in very early stages of the disease, such as stage 2 T1DM, when there are still enough beta cells to maintain euglycemia.

  4. Dulaglutide - Wikipedia

    en.wikipedia.org/wiki/Dulaglutide

    Dulaglutide, sold under the brand name Trulicity among others, [8] is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. [9] [10] It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

  5. US FDA says all doses of Lilly's weight-loss and diabetes ...

    www.aol.com/news/us-fda-says-doses-lillys...

    Lilly's Mounjaro has been on the U.S. FDA's shortage list since late 2022, while Zepbound was added to the list in April this year. US FDA says all doses of Lilly's weight-loss and diabetes drug ...

  6. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

  7. Canagliflozin - Wikipedia

    en.wikipedia.org/wiki/Canagliflozin

    Canagliflozin is indicated to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes; to reduce the risk of major heart-related events such as heart attack, stroke, or death in people with type 2 diabetes who have known heart disease; and to reduce the risk of end-stage kidney disease, worsening of kidney function, heart-related death, and being hospitalized for ...

  8. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  9. US FDA allows new claim that yogurt may reduce diabetes risk

    www.aol.com/news/us-fda-allows-claim-yogurt...

    NEW YORK (Reuters) -The U.S. Food and Drug Administration on Friday said it would allow yogurt makers to say that the dairy product may reduce the risk of type 2 diabetes as more Americans die ...